<p>以色列，Neve Yarak，2026 年 1 月 5 日（GLOBE NEWSWIRE）-- N2OFF, Inc.（纳斯达克：NITO）（“N2OFF” 和 “公司”）是一家药物发现公司，同时投资于基于 RTB（Ready to Build）商业模式的太阳能资产，宣布通过与 Solterra Renewable Energy Ltd.（“Solterra”）的合作，推动其欧洲投资组合的发展。正如 2025 年 12 月 29 日所宣布的，德国项目的关键里程碑，包括太阳能光伏和储能资产，已降低了许可风险，通过智能资本部署释放了价值，并为项目提供了引人注目的货币化选择。</p>
<p><strong>投资者重点</strong></p>
<ul>
<li>降低核心欧洲资产的许可和监管风险</li>
<li>提前支付 34 万美元，并在项目利润份额中获得有利条款</li>
<li>通过对开发经济的严格重新谈判，实现约 170 万美元的项目级价值创造</li>
<li>增强的货币化选择，多个高可见度的价值实现路径将于 2026 年下半年开始</li>
</ul>
<p><strong>德国更新：预计 2026 年第三季度获得批准，已确保节省</strong></p>
<p>N2OFF 在德国的旗舰太阳能项目已进入许可流程的最后阶段，并稳步朝着预计在 2026 年第三季度获得批准的目标前进。</p>
<p>第一次公众咨询阶段即将完成，目前没有反对意见或重大修改请求，这强烈表明了监管一致性、社区接受度和规划完整性。最终咨询阶段的草案区域规划提交定于 2026 年 1 月底假期后进行，保持了明确的发展时间表。</p>
<p>作为主动价值优化的示范，Solterra 表示上周已执行了开发协议的修订。Solterra 将获得约 34 万美元的预付款，以加快进度，作为交换，开发费用每兆瓦减少 11,000 欧元，从而增加潜在利润约 170 万美元。</p>
<p>从资本配置的角度来看，此交易代表了对有限短期资本的高效再部署，以显著改善长期项目经济，增加嵌入的股权价值，并增强未来的退出或运营回报。</p>
<p><strong>战略视角</strong></p>
<p>德国的最新进展推动了公司在 RTB 价值曲线上的欧洲投资组合。通过系统性地降低监管风险、收紧开发经济并保持货币化灵活性，N2OFF 继续将自己定位为专注于可扩展、基础设施支持的价值创造的严谨资本配置者。</p>
<p><strong>关于 N2OFF Inc:</strong></p>
<p>N2OFF 拥有 MitoCareX Bio Ltd.的 100% 股份，这是一家专注于通过线粒体 SLC25 蛋白家族进行癌症治疗和其他疾病药物发现的药物递送公司。此外，N2OFF 采用了一种投资策略，专注于利用 RTB（Ready to Build）商业模式的欧洲可再生能源资产。该公司目前是三个欧盟国家四个太阳能项目的主要投资者，所有项目均由 Solterra Renewable Energy Ltd.引入，后者是 Solterra Energy Ltd.的全资子公司。</p>
<p>N2OFF 还控制约 98% 的 Save Foods Ltd.，这是一家以色列公司，专注于减少水果和蔬菜中病原体污染的后收获处理技术。</p>
<p>欲了解更多信息，请访问 www.n2off.com。</p>
<p><strong>前瞻性声明：</strong></p>
<p>本新闻稿包含根据 1995 年《私人证券诉讼改革法案》和其他联邦证券法的 “安全港” 条款的前瞻性声明。诸如 “预计”、“预期”、“打算”、“计划”、“相信”、“寻求”、“估计” 等词语及其类似表达或变体旨在识别前瞻性声明。由于这些声明涉及未来事件并基于我们当前的预期，因此它们受到各种风险和不确定性的影响，包括我们与 Solterra Energy Ltd.的合作成功、进入未来项目的能力、我们成功进入太阳能光伏行业的能力、该行业的盈利能力以及增加产能的潜在附加价值。实际结果、表现或成就可能与本新闻稿中描述或暗示的内容有重大差异。本新闻稿中包含或暗示的前瞻性声明受到其他风险和不确定性的影响，包括市场条件以及在 N2OFF 于 2025 年 3 月 31 日向 SEC 提交的 10-K 年度报告中讨论的 “风险因素” 标题下的内容，以及任何后续向 SEC 提交的文件。除非法律另有要求，否则我们不承担公开发布任何修订前瞻性声明的义务，以反映本日期之后的事件或情况，或反映意外事件的发生。提供网站的引用和链接仅为方便，网站上包含的信息不被纳入本新闻稿。我们对第三方网站的内容不承担任何责任。</p>
<p>投资者关系联系人：</p>
<p>Michal Efraty</p>
<p>michal@efraty.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeE9UYzFNeU0zTXpRME16TXlJelV3TURBMU16WTJOZz09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeE9UYzFNeU0zTXpRME16TXlJelV3TURBMU16WTJOZz09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/M2RhMzQ0OGQtMjgyOC00NmFmLTg4Y2QtNzZjYmFkOGZmZmQ2LTUwMDA1MzY2Ni0yMDI2LTAxLTA1LWVu/tiny/N2OFF-Inc-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/M2RhMzQ0OGQtMjgyOC00NmFmLTg4Y2QtNzZjYmFkOGZmZmQ2LTUwMDA1MzY2Ni0yMDI2LTAxLTA1LWVu/tiny/N2OFF-Inc-.png"/></p>

NITO

<p>N2OFF, Inc.（纳斯达克代码：NITO）已向 Solterra Renewable Energy Ltd.预付 34 万美元，以确保其太阳能项目获得更好的条款，这可能使项目利润增加约 170 万美元。该公司预计将在 2026 年第三季度获得其旗舰德国太阳能项目的批准，降低了许可风险并增强了货币化选项。这一战略举措反映了 N2OFF 在欧洲可再生能源资产中专注于严格的资本配置和价值创造</p>

<p>Neve Yarak, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business model, announced advancement in its European portfolio via its partnership with Solterra Renewable Energy Ltd. (“Solterra”). As announced on December 29, 2025, key milestones in Germany project, which includes solar energy PV and storage assets, have reduced permitting risks, unlocked value through smart capital deployment, and positioned projects for compelling monetization optionality.</p>
<div class="lb-trans"><p>以色列，Neve Yarak，2026 年 1 月 5 日（GLOBE NEWSWIRE）-- N2OFF, Inc.（纳斯达克：NITO）（“N2OFF” 和 “公司”）是一家药物发现公司，同时投资于基于 RTB（Ready to Build）商业模式的太阳能资产，宣布通过与 Solterra Renewable Energy Ltd.（“Solterra”）的合作，推动其欧洲投资组合的发展。正如 2025 年 12 月 29 日所宣布的，德国项目的关键里程碑，包括太阳能光伏和储能资产，已降低了许可风险，通过智能资本部署释放了价值，并为项目提供了引人注目的货币化选择。</p>
</div><p><strong>Key Investor Highlights</strong></p>
<div class="lb-trans"><p><strong>投资者重点</strong></p>
</div><ul>
<li>Reduction in permitting and regulatory risk across core European assets</li>
<li>Advanced payment of $340,000 and receiving favourable terms in the project’s profit stake</li>
<li>Approximately $1.7 million in project-level value creation achieved through disciplined renegotiation of development economics</li>
<li>Enhanced monetization optionality, with multiple high-visibility pathways to value realization beginning in H2 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>降低核心欧洲资产的许可和监管风险</li>
<li>提前支付 34 万美元，并在项目利润份额中获得有利条款</li>
<li>通过对开发经济的严格重新谈判，实现约 170 万美元的项目级价值创造</li>
<li>增强的货币化选择，多个高可见度的价值实现路径将于 2026 年下半年开始</li>
</ul>
</div><p><strong>Germany Update: on track for Q3 2026 approval with savings secured</strong></p>
<div class="lb-trans"><p><strong>德国更新：预计 2026 年第三季度获得批准，已确保节省</strong></p>
</div><p>N2OFF’s flagship German solar project has advanced into the final stages of the permitting process and remains firmly on track toward expected approval in Q3 2026.</p>
<div class="lb-trans"><p>N2OFF 在德国的旗舰太阳能项目已进入许可流程的最后阶段，并稳步朝着预计在 2026 年第三季度获得批准的目标前进。</p>
</div><p>The first public consultation phase is nearing completion with no objections or material modification requests to date, a strong indicator of regulatory alignment, community acceptance, and planning integrity. Submission of the draft zoning plan for the final consultation phase is scheduled for late January 2026 following the holiday period, maintaining a clear development timeline.</p>
<div class="lb-trans"><p>第一次公众咨询阶段即将完成，目前没有反对意见或重大修改请求，这强烈表明了监管一致性、社区接受度和规划完整性。最终咨询阶段的草案区域规划提交定于 2026 年 1 月底假期后进行，保持了明确的发展时间表。</p>
</div><p>In a demonstration of proactive value optimization, Solterra has indicated that an amendment to the development agreement was executed last week. Solterra will receive approximately $340,000 in advance funding to fuel faster progress, in exchange for a €11,000 per MW reduction in development fees, thereby increasing potential profit with approximately $ 1.7 million.</p>
<div class="lb-trans"><p>作为主动价值优化的示范，Solterra 表示上周已执行了开发协议的修订。Solterra 将获得约 34 万美元的预付款，以加快进度，作为交换，开发费用每兆瓦减少 11,000 欧元，从而增加潜在利润约 170 万美元。</p>
</div><p>From a capital allocation perspective, this transaction represents a highly efficient redeployment of limited near-term capital to materially improve long-term project economics, increase embedded equity value, and enhance future exit or operating returns.</p>
<div class="lb-trans"><p>从资本配置的角度来看，此交易代表了对有限短期资本的高效再部署，以显著改善长期项目经济，增加嵌入的股权价值，并增强未来的退出或运营回报。</p>
</div><p><strong>Strategic Perspective</strong></p>
<div class="lb-trans"><p><strong>战略视角</strong></p>
</div><p>The recent developments in Germany advance the Company’s European portfolio along the RTB value curve. By systematically reducing regulatory risk, tightening development economics, and preserving monetization flexibility, N2OFF continues to position itself as a disciplined capital allocator focused on scalable, infrastructure-backed value creation.</p>
<div class="lb-trans"><p>德国的最新进展推动了公司在 RTB 价值曲线上的欧洲投资组合。通过系统性地降低监管风险、收紧开发经济并保持货币化灵活性，N2OFF 继续将自己定位为专注于可扩展、基础设施支持的价值创造的严谨资本配置者。</p>
</div><p><strong>About N2OFF Inc:</strong></p>
<div class="lb-trans"><p><strong>关于 N2OFF Inc:</strong></p>
</div><p>N2OFF owns 100% of MitoCareX Bio Ltd, a drug delivery company engaged in drug discovery targeting cancer therapeutics and other diseases through the mitochondrial SLC25 protein family. Additionally, N2OFF adopted an investment strategy focused on European renewable energy assets utilizing a RTB (Ready to Build ) business model. The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd</p>
<div class="lb-trans"><p>N2OFF 拥有 MitoCareX Bio Ltd.的 100% 股份，这是一家专注于通过线粒体 SLC25 蛋白家族进行癌症治疗和其他疾病药物发现的药物递送公司。此外，N2OFF 采用了一种投资策略，专注于利用 RTB（Ready to Build）商业模式的欧洲可再生能源资产。该公司目前是三个欧盟国家四个太阳能项目的主要投资者，所有项目均由 Solterra Renewable Energy Ltd.引入，后者是 Solterra Energy Ltd.的全资子公司。</p>
</div><p>N2OFF also controls approximately 98% of Save Foods Ltd., an Israeli company focused on post-harvest treatment technologies designed to reduce pathogen contamination in fruits and vegetables.</p>
<div class="lb-trans"><p>N2OFF 还控制约 98% 的 Save Foods Ltd.，这是一家以色列公司，专注于减少水果和蔬菜中病原体污染的后收获处理技术。</p>
</div><p>For more information, please visit www.n2off.com.</p>
<div class="lb-trans"><p>欲了解更多信息，请访问 www.n2off.com。</p>
</div><p><strong>Forward-looking Statements:</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明：</strong></p>
</div><p>This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on our current expectations, they are subject to various risks and uncertainties including the success of our collaboration with Solterra Energy Ltd., entry into future projects, our ability to successfully enter the solar PV sector, the profitability of such industry, and the potential added value of the increased capacity. Actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including market conditions as well as those discussed under the heading “Risk Factors” in N2OFF’s Annual Report on Form 10-K filed with the SEC on March 31, 2025, and in any subsequent filings with the SEC. Except as otherwise required by law, we undertake no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. We are not responsible for the contents of third-party websites.</p>
<div class="lb-trans"><p>本新闻稿包含根据 1995 年《私人证券诉讼改革法案》和其他联邦证券法的 “安全港” 条款的前瞻性声明。诸如 “预计”、“预期”、“打算”、“计划”、“相信”、“寻求”、“估计” 等词语及其类似表达或变体旨在识别前瞻性声明。由于这些声明涉及未来事件并基于我们当前的预期，因此它们受到各种风险和不确定性的影响，包括我们与 Solterra Energy Ltd.的合作成功、进入未来项目的能力、我们成功进入太阳能光伏行业的能力、该行业的盈利能力以及增加产能的潜在附加价值。实际结果、表现或成就可能与本新闻稿中描述或暗示的内容有重大差异。本新闻稿中包含或暗示的前瞻性声明受到其他风险和不确定性的影响，包括市场条件以及在 N2OFF 于 2025 年 3 月 31 日向 SEC 提交的 10-K 年度报告中讨论的 “风险因素” 标题下的内容，以及任何后续向 SEC 提交的文件。除非法律另有要求，否则我们不承担公开发布任何修订前瞻性声明的义务，以反映本日期之后的事件或情况，或反映意外事件的发生。提供网站的引用和链接仅为方便，网站上包含的信息不被纳入本新闻稿。我们对第三方网站的内容不承担任何责任。</p>
</div><p>Investor Relations Contact:</p>
<div class="lb-trans"><p>投资者关系联系人：</p>
</div><p>Michal Efraty</p>
<div class="lb-trans"><p>Michal Efraty</p>
</div><p>michal@efraty.com</p>
<div class="lb-trans"><p>michal@efraty.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeE9UYzFNeU0zTXpRME16TXlJelV3TURBMU16WTJOZz09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYxOTc1MyM3MzQ0MzMyIzUwMDA1MzY2Ng=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/M2RhMzQ0OGQtMjgyOC00NmFmLTg4Y2QtNzZjYmFkOGZmZmQ2LTUwMDA1MzY2Ni0yMDI2LTAxLTA1LWVu/tiny/N2OFF-Inc-.png" alt="" original-src="https://ml.globenewswire.com/media/M2RhMzQ0OGQtMjgyOC00NmFmLTg4Y2QtNzZjYmFkOGZmZmQ2LTUwMDA1MzY2Ni0yMDI2LTAxLTA1LWVu/tiny/N2OFF-Inc-.png"/></p>

N2OFF Advances $340,000 Payment to Gain Better Terms in Flag Solar Energy Initiative, Reflecting Approximately an Additional $1.7 Million in Project Profit Stake | NITO Stock News

N2OFF 预付 34 万美元以获得更优惠的条款，这反映出在 Flag 太阳能项目中额外约 170 万美元的项目利润份额 | NITO 股票新闻